更多Health Tech相关内容
STAT News
STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
STAT News
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
STAT News
STAT+: UnitedHealth’s Democrat investment, and surprise billing bloat debate
STAT News
STAT+: Oura files to goes public, reported $1.2B in earnings
STAT News
STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more
STAT News
STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
相关洞察
Future Supply Chains, Logistics & Fleets
The Supply Chain That Thinks - How AI agents, quantum computing, cheap energy and programmable risk could reshape global logistics, 2026–2036
19 min read
Synthetic biology and bioengineeringThe Bio Revolution Is Here — And the World Is Already Choosing Sides
Biology is becoming the next great industrial platform — accelerated by AI, contested by China and the US, and creating tomorrow's careers.
15 min read